Our metabolomic and “diricore” analyses indicated that ASNase‐treated SLC1A3‐expressing cancer cells and tumors still present asparagine shortage (Fig 5A and C; Loayza‐Puch et al, 2016). The gene discussed is SLC1A3; the disease is cancer.